Dr. Christopher Lafargue, M.D
NPI: 1306286166
Total Payments
$19,847
2024 Payments
$6,687
Companies
13
Transactions
53
Medicare Patients
2,273
Medicare Billing
$1.2M
Payment Breakdown by Category
Consulting$18,397 (92.7%)
Food & Beverage$1,175 (5.9%)
Education$274.94 (1.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $18,397 | 6 | 92.7% |
| Food and Beverage | $1,175 | 45 | 5.9% |
| Education | $274.94 | 2 | 1.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $6,371 | 11 | $0 (2024) |
| GlaxoSmithKline, LLC. | $6,084 | 8 | $0 (2024) |
| Eisai Inc. | $3,512 | 12 | $0 (2024) |
| Seagen Inc. | $3,072 | 2 | $0 (2022) |
| Stryker Corporation | $428.55 | 5 | $0 (2022) |
| Merck Sharp & Dohme LLC | $91.76 | 3 | $0 (2024) |
| Genmab U.S., Inc. | $82.59 | 3 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $68.58 | 3 | $0 (2024) |
| ABBVIE INC. | $45.70 | 2 | $0 (2024) |
| Medtronic, Inc. | $33.87 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $6,687 | 24 | AstraZeneca Pharmaceuticals LP ($6,229) |
| 2023 | $9,506 | 14 | GlaxoSmithKline, LLC. ($6,035) |
| 2022 | $3,351 | 11 | Seagen Inc. ($3,072) |
| 2021 | $303.50 | 4 | Stryker Corporation ($287.06) |
All Payment Transactions
53 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Medtronic, Inc. | LIGASURE (Device) | Food and Beverage | In-kind items and services | $33.87 | General |
| Category: Vessel Sealing | ||||||
| 12/11/2024 | ABBVIE INC. | ELAHERE (Drug) | Food and Beverage | In-kind items and services | $24.77 | General |
| Category: ONCOLOGY | ||||||
| 12/09/2024 | Merck Sharp & Dohme LLC | LYNPARZA (Biological) | Food and Beverage | In-kind items and services | $34.46 | General |
| Category: ONCOLOGY | ||||||
| 12/04/2024 | Integra LifeSciences Corporation | CODMAN CERTAS (Device), CUSA CLARITY, CODMAN HAKIM | Food and Beverage | In-kind items and services | $22.58 | General |
| Category: Neuro Critical Care | ||||||
| 10/15/2024 | GlaxoSmithKline, LLC. | JEMPERLI (Biological), ZEJULA | Food and Beverage | In-kind items and services | $15.64 | General |
| Category: ONCOLOGY | ||||||
| 10/10/2024 | AstraZeneca Pharmaceuticals LP | ENHERTU (Biological) | Consulting Fee | Cash or cash equivalent | $3,425.00 | General |
| Category: Oncology | ||||||
| 10/10/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $21.37 | General |
| Category: Oncology | ||||||
| 09/25/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $31.73 | General |
| Category: Oncology | ||||||
| 09/12/2024 | AstraZeneca Pharmaceuticals LP | — | Consulting Fee | Cash or cash equivalent | $2,740.00 | General |
| 08/12/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $31.84 | General |
| Category: Oncology | ||||||
| 08/08/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $20.35 | General |
| Category: Oncology | ||||||
| 07/17/2024 | Genmab U.S., Inc. | Tivdak (Drug) | Food and Beverage | In-kind items and services | $28.48 | General |
| Category: Oncology | ||||||
| 07/08/2024 | GlaxoSmithKline, LLC. | JEMPERLI (Biological), ZEJULA | Food and Beverage | In-kind items and services | $18.21 | General |
| Category: ONCOLOGY | ||||||
| 06/26/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $18.64 | General |
| Category: Biological | ||||||
| 06/19/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $18.78 | General |
| Category: Oncology | ||||||
| 04/24/2024 | ABBVIE INC. | ELAHERE (Drug) | Food and Beverage | In-kind items and services | $20.93 | General |
| Category: ONCOLOGY | ||||||
| 04/05/2024 | Novartis Pharmaceuticals Corporation | MEKINIST (Drug) | Food and Beverage | In-kind items and services | $25.16 | General |
| Category: Oncology | ||||||
| 03/27/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $20.02 | General |
| Category: Oncology | ||||||
| 02/14/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $25.58 | General |
| Category: ONCOLOGY | ||||||
| 02/07/2024 | Novartis Pharmaceuticals Corporation | MEKINIST (Drug) | Food and Beverage | In-kind items and services | $18.79 | General |
| Category: Oncology | ||||||
| 01/31/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $25.78 | General |
| Category: Oncology | ||||||
| 01/25/2024 | GlaxoSmithKline, LLC. | ZEJULA (Drug), JEMPERLI | Food and Beverage | In-kind items and services | $14.98 | General |
| Category: ONCOLOGY | ||||||
| 01/18/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $21.98 | General |
| Category: Oncology | ||||||
| 01/11/2024 | Genmab U.S., Inc. | Tivdak (Drug) | Food and Beverage | In-kind items and services | $27.70 | General |
| Category: Oncology | ||||||
| 12/08/2023 | GlaxoSmithKline, LLC. | JEMPERLI (Biological) | Consulting Fee | Cash or cash equivalent | $3,200.00 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 38 | 1,142 | 36,040 | $2.5M | $562,100 |
| 2022 | 35 | 978 | 31,787 | $2.6M | $627,065 |
| 2021 | 10 | 153 | 490 | $42,594 | $7,334 |
Total Patients
2,273
Total Services
68,317
Medicare Billing
$1.2M
Procedure Codes
83
All Medicare Procedures & Services
83 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J9271 | Injection, pembrolizumab, 1 mg | Office | 2023 | 24 | 10,300 | $1.4M | $446,748 | 31.5% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 87 | 205 | $144,935 | $21,028 | 14.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 62 | 202 | $74,336 | $19,459 | 26.2% |
| 78815 | Nuclear medicine study from skull base to mid-thigh with ct scan | Office | 2023 | 14 | 17 | $81,634 | $18,759 | 23.0% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 11 | 40 | $147,000 | $5,439 | 3.7% |
| 96401 | Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 18 | 81 | $17,091 | $4,649 | 27.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 50 | 65 | $16,250 | $4,401 | 27.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 25 | 30 | $14,880 | $4,222 | 28.4% |
| 86304 | Immunologic analysis for detection of tumor antigen, quantitative; ca 125 | Office | 2023 | 64 | 172 | $22,016 | $3,507 | 15.9% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 39 | 67 | $20,971 | $3,276 | 15.6% |
| 96417 | Administration of additional new drug or substance into vein, 1 hour or less | Office | 2023 | 28 | 64 | $22,016 | $3,248 | 14.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 19 | 19 | $13,471 | $3,202 | 23.8% |
| 96375 | Injection of additional new drug or substance into vein | Office | 2023 | 64 | 223 | $24,084 | $2,716 | 11.3% |
| 96367 | Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | Office | 2023 | 45 | 114 | $17,898 | $2,603 | 14.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 18 | 18 | $10,170 | $2,351 | 23.1% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 40 | 209 | $13,376 | $2,163 | 16.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 74 | 251 | $5,020 | $2,108 | 42.0% |
| J9025 | Injection, azacitidine, 1 mg | Office | 2023 | 12 | 5,500 | $71,500 | $1,866 | 2.6% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 36 | 205 | $7,380 | $1,560 | 21.1% |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | Office | 2023 | 14 | 17 | $11,169 | $1,430 | 12.8% |
| 96415 | Administration of chemotherapy into vein, each additional hour | Office | 2023 | 18 | 49 | $7,889 | $1,089 | 13.8% |
| J1453 | Injection, fosaprepitant, 1 mg | Office | 2023 | 26 | 8,400 | $42,000 | $993.75 | 2.4% |
| J3489 | Injection, zoledronic acid, 1 mg | Office | 2023 | 19 | 113 | $48,703 | $729.11 | 1.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 25 | 65 | $6,240 | $712.98 | 11.4% |
| J9267 | Injection, paclitaxel, 1 mg | Office | 2023 | 18 | 6,636 | $53,088 | $647.63 | 1.2% |
About Dr. Christopher Lafargue, M.D
Dr. Christopher Lafargue, M.D is a Student in an Organized Health Care Education/Training Program healthcare provider based in Fort Worth, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/26/2013. The National Provider Identifier (NPI) number assigned to this provider is 1306286166.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Lafargue, M.D has received a total of $19,847 in payments from pharmaceutical and medical device companies, with $6,687 received in 2024. These payments were reported across 53 transactions from 13 companies. The most common payment nature is "Consulting Fee" ($18,397).
As a Medicare-enrolled provider, Lafargue has provided services to 2,273 Medicare beneficiaries, totaling 68,317 services with total Medicare billing of $1.2M. Data is available for 3 years (2021–2023), covering 83 distinct procedure/service records.
Ad
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Gynecologic Oncology
- Location Fort Worth, TX
- Active Since 06/26/2013
- Last Updated 09/14/2021
- Taxonomy Code 390200000X
- Entity Type Individual
- NPI Number 1306286166
Products in Payments
- JEMPERLI (Biological) $6,034
- Lenvima (Drug) $3,512
- ENHERTU (Biological) $3,425
- TIVDAK (Biological) $2,972
- LYNPARZA (Drug) $205.90
- SPY-PHI SYSTEM (Device) $195.42
- MEKINIST (Drug) $68.58
- IRIS (Device) $58.14
- KEYTRUDA (Biological) $57.30
- Tivdak (Drug) $56.18
- ZEJULA (Drug) $49.77
- ELAHERE (Drug) $45.70
- LYNPARZA (Biological) $34.46
- LIGASURE (Device) $33.87
- TIVDAK (Drug) $26.41
- CODMAN CERTAS (Device) $22.58
- Veozah (Drug) $18.64
- Elahere (Biological) $15.77
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Fort Worth
Dr. Richard Teames, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $679,444
Student in an Organized Health Care Education/Training Program $679,444
Jeremy Ross, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $347,288
Student in an Organized Health Care Education/Training Program $347,288
Brett Mueller, Do, Phd, DO, PHD
Student in an Organized Health Care Education/Training Program — Payments: $114,196
Student in an Organized Health Care Education/Training Program $114,196
Herman Kao, Dds, Md, DDS, MD
Student in an Organized Health Care Education/Training Program — Payments: $57,014
Student in an Organized Health Care Education/Training Program $57,014
Dr. Natalia Chaimowitz, M.d., Ph.d, M.D., PH.D
Student in an Organized Health Care Education/Training Program — Payments: $40,250
Student in an Organized Health Care Education/Training Program $40,250
Dr. Joshua Payne, D.o, D.O
Student in an Organized Health Care Education/Training Program — Payments: $22,289
Student in an Organized Health Care Education/Training Program $22,289